InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,588.27
(
0.00%
)
US TECH 100
19,440.00
(
0.88%
)
Dow Jones
41,198.08
(
0.00%
)
Brent Oil
84.42
(
-0.08%
)
Bitcoin
65,032.49
(
1.48%
)
Post# of 464410
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Jimmy6969

Send PM Follow Ignore
Followers 15
Posts 540
Boards Moderated 0
Alias Born 11/11/2012

Jimmy6969

Re: Jimbo50 post# 82598

Thursday, 12/08/2016 3:33:18 PM

Thursday, December 08, 2016 3:33:18 PM

Post# of 464410
I'm not sure I follow the correlation between a secondary and the admission of the molecule being useless. Have other biotechs done a secondary in the past only to discover that there molecule was worth something more than being useless? I get the spreading risk part, just don't get the last part.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News
InvestorsHub NewsWire

FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM

FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM

VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM

Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM

Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM

HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM

Start posting your company's news
Only $200 per official company press release!